EUVIMEDEUVIMED entdecken
Crossref

Ordering molecular genetic tests: Clinician considerations and precautions

Anupkumar Rawool, Vrushali Anupkumar Rawool

Wadia Journal of Women and Child Health · 09.03.2026 · 4 · 103-105

DOI: 10.25259/wjwch_30_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wadia Journal of Women and Child Health, online erschienen am 09.03.2026. Verfasst von Anupkumar Rawool und 1 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular genetic testing including targeted panels, whole-exome sequencing (WES), whole-genome sequencing, and somatic mutation analysis is increasingly becoming pivotal in clinical medicine. These tools aid in diagnosis, prognosis, treatment selection, and familial risk assessment. However, effective test utilization requires careful attention to analytical validity, clinical utility, informed consent, result interpretation, and ethical, legal, and societal implications. This review outlines clinician-oriented considerations and precautions across the pre-analytic, analytic, and post-analytic phases of testing, emphasizing multidisciplinary interpretation, patient-centered counseling, and the evolving governance landscape.

Zitieren

APA

Rawool, A., & Rawool, V. A. (2026). Ordering molecular genetic tests: Clinician considerations and precautions. Wadia Journal of Women and Child Health, 4, 103-105. https://doi.org/10.25259/wjwch_30_2025

Vancouver

Rawool A, Rawool VA. Ordering molecular genetic tests: Clinician considerations and precautions. Wadia Journal of Women and Child Health. 2026;4:103-105. doi:10.25259/wjwch_30_2025

BibTeX
@article{Rawool2026,
  author = {Rawool, Anupkumar and Rawool, Vrushali Anupkumar},
  title = {Ordering molecular genetic tests: Clinician considerations and precautions},
  journal = {Wadia Journal of Women and Child Health},
  year = {2026},
  volume = {4},
  pages = {103--105},
  doi = {10.25259/wjwch_30_2025}
}
Kostenlos starten →